Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Supriya Lifescience Limited ( (IN:SUPRIYA) ) is now available.
Supriya Lifescience Limited has announced the closure of its trading window for company securities for all insiders and designated persons, including their immediate relatives, in line with SEBI (Prohibition of Insider Trading) Regulations, 2015 and its internal code of conduct. The window will remain closed from January 1, 2026 until 48 hours after the company announces its unaudited financial results for the quarter and nine months ended December 31, 2025, underscoring its adherence to governance norms and insider trading safeguards, with the date of the board meeting to approve these results to be communicated later to the market.
More about Supriya Lifescience Limited
Supriya Lifescience Limited is an Indian pharmaceutical company engaged in the manufacturing and export of active pharmaceutical ingredients (APIs) and related specialty chemicals, operating production facilities in Maharashtra and serving both domestic and international markets.
Average Trading Volume: 13,687
Technical Sentiment Signal: Buy
Current Market Cap: 59.46B INR
Learn more about SUPRIYA stock on TipRanks’ Stock Analysis page.